Rochester, NY 9/2/2009 11:51:19 PM
First Trust Amex Biotech FBT, a year returns for FBT
First Trust Amex Biotech
First Trust Amex Biotech (FBT) is one of them. Similarly, biotech ETFs and pharma ETFs collectively account for some of the best 1-year performers on the 1-year scoreboard. Drug developers (biotech) have a history of volatility due to the hit-or-miss nature of creating the next big “thing’ or developing a ”flop.” Still, biotech has risk reduction qualities as a diversifier in one’s portfolio, as biotech ETFs had the lowest correlation with the S&P 500 in the 2007-2009 bear.It follows that very few unleveraged ETFs are able to claim 1-year gains; 4 to be exact.
StockEinstein.com offers free trading alerts on stocks about to run. To sign up for our free alert service please click here www.stockeinstein.com or scroll to bottom of this page to sign up.Last Trade: 27.15
Trade Time: 12:03pm ET
Change: Down 0.190001 (0.69%)
Prev Close: 27.34
Open: 27.129999
Day's Range: 26.8906 - 27.23
52wk Range: 15.44 - 29.20
Volume: 40,773
Avg Vol (3m): 61,681.8
About First Trust Amex Biotech
First Trust NYSE Arca Biotechnology Index Fund (the Fund), formerly First Trust Amex Biotechnology Index Fund, is an exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The Fund is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Such processes include, but are not limited to, recombinant deoxyribonucleic acid technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics. The index is rebalanced quarterly based on closing prices on the third Friday in January, April, July and October. The Fund’s investment advisor is First Trust Advisors L.P.
About StockEinstein
StockEinstein.com uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll down this page or visit our site to join our free newsletter and begin receiving daily stock alerts.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
